NEURAEGIS, INC.
NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. Founded in 2016, our initial focus is developing first-in-class, novel protease inhibitors for mild traumatic brain injury (concussion) where there are currently no FDA approved treatments.
NEURAEGIS, INC.
Social Links:
Industry:
Biotechnology Health Care Neuroscience Pharmaceutical
Founded:
2016-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.neuraegis.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Combat Casualty Care Research Program
Combat Casualty Care Research Program investment in Grant - NeurAegis, Inc.
Official Site Inspections
http://www.neuraegis.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "NeurAegis, Inc."
HOME | NeurAegis Inc.
NeurAegis, Inc. is a late preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders including traumatic brain …See details»
NeurAegis, Inc. - Crunchbase Company Profile & Funding
NeurAegis is a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. View contacts for NeurAegis, Inc. to access new leads and connect with decision-makers.See details»
TEAM | NeurAegis Inc.
Collectively, the NeurAegis Leadership Team has... World-renowned neuroscientist, life science entrepreneur and professor. Co-Founder of 5 biotechnology companies across two countries. Identified calpain-2’s role in …See details»
SCIENCE | NeurAegis Inc.
NeurAegis founder, Dr. Michel Baudry, discovered the role of calpain-2 protease in neurodegeneration. NeurAegis’s lead clinical candidate, NA184, selectively inhibits calpain-2, a key protease causing neurodegeneration.See details»
NeurAegis Company Profile 2024: Valuation, Funding & Investors
Developer of neuropharmaceutical therapies intended for the treatment of neurological disorders. The company's therapies are focused on novel protease inhibitors for concussion including …See details»
NeurAegis, Inc. - LinkedIn
NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. Founded in 2016, our initial focus is developing...See details»
NeurAegis, Inc. Company Profile | Irvine, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NeurAegis, Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»
NeurAegis Announces Formation of Scientific-Medical …
Dec 10, 2020 · NeurAegis, Inc. is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders including TBI, epilepsy, mild cognitive...See details»
NeurAegis, Inc. - Contacts, Employees, Board Members
NeurAegis is a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders.See details»
NeurAegis Scientific Founder Michel Baudry Awarded $3.8M Grant …
Sep 5, 2019 · NeurAegis, Inc. is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders including TBI, epilepsy, …See details»
NeurAegis' Board of Directors Team - Team members and org …
The board of directors at NeurAegis has a history of experience in the biotech industry and academia. Many of the members have worked as consultants, directors, and associate …See details»
Scientific & Clinical Advisor at NeurAegis - The Org
Scientific & Clinical Advisor at NeurAegis. Contact. About. Dr. Diaz-Arrastia is the Presidential Professor of Neurology and Director of Clinical Traumatic Brain Injury (TBI) Research at Penn …See details»
NeurAegis Company Profile - Office Locations, Competitors ... - Craft
NeurAegis is a neuropharmaceutical company providing treatments for neurological disorders. It is focused on the development of protease inhibitors for mild traumatic brain injury (concussion).See details»
Scientific & Clinical Advisor at NeurAegis - The Org
Dr. Palfreyman is an internationally recognized leader in neurological drug development with a successful scientific and business career spanning 35 years. He brings to NeurAegis a …See details»
NeurAegis - VentureRadar
Website: https://www.neuraegis.com/ Develops innovative therapies targeting neurodegenerative diseases, focusing on Alzheimer's, Parkinson's, and related disorders, aiming to improve …See details»
NeurAegis - Overview, News & Similar companies | ZoomInfo.com
NeurAegis contact info: Phone number: (650) 269-3528 Website: www.neuraegis.com What does NeurAegis do? NeurAegis, Inc. is a preclinical stage neuropharmaceutical company …See details»
Philippe Bey - Scientific Advisor at NeurAegis - The Org
Scientific Advisor at NeurAegis. Contact. Join to edit. About. Dr. Bey has participated in and led teams responsible for over 30 INDs in many therapeutic areas, including oncology, respiratory …See details»
NeurAegis NA101 is neuroprotective in a mouse model of …
Jul 20, 2017 · NeurAegis ( www.neuraegis.com) has been founded to translate fundamental discoveries on the mechanisms of synaptic plasticity and neuronal survival/cell death into …See details»
Kathy Fosnaugh - Consultant at NeurAegis - The Org
Kathy Fosnaugh is currently a consultant at NeurAegis. Kathy has also previously worked as the Director at Youtell Biochemical Inc., the Associate Director at Marina Biotech, Inc., and as a …See details»
NeurAegis Announces Publication of Preclinical Animal Data …
Feb 18, 2021 · NeurAegis, Inc. is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders including TBI, epilepsy, …See details»